Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Osteocalcin Antikörper (N-Term)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Osteocalcin in WB, IHC (p) und EIA. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN357367

Kurzübersicht für Osteocalcin Antikörper (N-Term) (ABIN357367)

Target

Alle Osteocalcin (BGLAP) Antikörper anzeigen
Osteocalcin (BGLAP)

Reaktivität

  • 103
  • 32
  • 19
  • 19
  • 18
  • 12
  • 9
  • 9
  • 8
  • 5
  • 4
  • 1
  • 1
  • 1
Human

Wirt

  • 84
  • 50
  • 3
  • 2
  • 1
Kaninchen

Klonalität

  • 89
  • 51
Polyklonal

Konjugat

  • 94
  • 12
  • 12
  • 7
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Osteocalcin Antikörper ist unkonjugiert

Applikation

  • 98
  • 76
  • 67
  • 37
  • 32
  • 8
  • 8
  • 7
  • 6
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 10
    • 9
    • 8
    • 8
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 9-39, N-Term

    Spezifität

    This antibody detects Osteocalcin at N-term.

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human.

    Aufreinigung

    Protein G Chromatography, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS

    Immunogen

    Synthetic peptide KLH conjugated between 9~39 amino acids from the N-terminal region of Human Osteocalcin.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    ELISA: 1/1,000. Western blot: 1/100-1/500. Immunohistochemistry: 1/50-1/100.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.25 mg/mL

    Buffer

    PBS with 0.09 % (W/V) Sodium Azide as preservative

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
  • Target

    Osteocalcin (BGLAP)

    Andere Bezeichnung

    Osteocalcin

    Hintergrund

    Prior to the formation of calcified bone, noncollagenous proteins form in the extracellular bone matrix. Gamma-carboxyglutamic acid residues are formed by vitamin K, vitamin-D regulated calcium binding proteins containing residues of Gla. These residues are essential for the binding of calcium and constitue 1-2 % of total bone protein. Osteocalcin itself binds strongly to apatite and calcium. Production of osteocalcin is expressed late in normal bone development and is characteristic of mature osteoblasts. Regular osteocalcin production has been shown to be linked to the p53 tumor suppressor gene. The p53 gene undergoes rearrangement in a high percentage of osteosarcomas, resulting in loss of its expression. The loss of p53 regulation inhibits further osteocalcin production. The absence of end-point differentiation in bone due to p53 rearrangements and lack of osteocalcin production may contribute to the maintenance of the tumorigenic phenotype in osteosarcomas.Synonyms: BGLAP, Bone Gla protein, Gamma-carboxyglutamic acid-containing protein

    Molekulargewicht

    10962 Da

    Gen-ID

    632

    NCBI Accession

    NP_954642

    UniProt

    P02818
Sie sind hier:
Chat with us!